EQS-News: invIOs GmbH / Key word(s): Study results invIOs GmbH: APEIRON Respiratory Therapies announces positive results from Phase I trial of inhaled APN01 03.11.2022 / 08:00 CET/CEST The issuer is solely responsible for the content of this announcement. APEIRON Respiratory Therapies announce.
EQS-News: Reset Pharmaceuticals, Inc. / Key word(s): Personnel Reset Pharmaceuticals announces appointment of neuroscience industry leader Lisa Deschamps to the Board of Directors 02.11.2022 / 13:00 CET/CEST The issuer is solely responsible for the content of this announcement. Reset Pharmaceut.
Spexis AG / Key word(s): Conference Spexis to present at BIO-Europe® 2022 18.10.2022 / 07:30 CET/CEST Allschwil, Switzerland, October 18, 2022 Spexis to present at BIO-Europe® 2022 Spexis AG (SIX: SPEX) today announced that the company will present and participate in one-on-one meetings at BIO-E.
Spexis AG / Key word(s): Conference Spexis to present at BIO-Europe 2022 18.10.2022 / 07:30 CET/CEST Allschwil, Switzerland, October 18, 2022 Spexis to present at BIO-Europe 2022